Nanoparticle dispersions for pulmonary delivery of antiviral drugs to combat COVID-19

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: NS/C000001/1

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $20,040.59
  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

    Pending
  • Research Location

    United Kingdom, Europe
  • Lead Research Institution

    University of Liverpool
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Limited ventilator availability is currently a global issue. This project aims to provide an alternative to ventilation by building upon ongoing solid drug nanoparticle formulation research of antivirals to develop therapeutic nebulised medicine options for COVID-19 treatment